57279.1 IP-LS

Résumé

B-BRB-seq: end-to-end high-throughput RNA sequencing of blood samples for next-gen biomarker discovery.

Textes supplémentaires

Abstract

We propose to develop B-BRB-seq, a novel RNA quantification method for the complete, cost-efficient and high-throughput analysis of blood samples.\nBRB-seq will enable, for the first time, comprehensive RNA profiling of large blood biobanks and the generation of novel RNA-based blood biomarkers.

Participants

Bart Deplancke

Kontaktperson

bart.deplancke@epfl.ch

EPFL Bart Deplancke Station 19, Bâtiment AI 1147 1015 Lausanne VD CH

Riccardo Dainese

Wirtschaftspartner

Alithea Genomics SA CHE-218.846.606 Riccardo Dainese EPFL - SV IBI-SV Station 19 1015 Lausanne VD CH

Détails du projet

Office de recherche: INNOSUISSE
Statut du projet: Abgeschlossen
Type de projet: Forschungsprojekt
Date de début: 2021-12-31
Date de fin: 2023-06-30
Coûts totaux approuvés: CHF 350930.40
Section: 60 Life Sciences
Domaine politique NABS: Industrielle Produktivität und Technologie

Disciplines de recherche

T490 Biotechnology 100.0%